Hyperliquid Strategies (NASDAQ:PURR) Shares Gap Up - Here's Why

Key Points

• Hyperliquid Strategies shares jumped at the open, rising from a prior close of $9.97 to $11.28 before trading around $10.93 on heavy volume of more than 11.3 million shares.
• Analyst views are mixed, with recent downgrades to “hold” and “sell” offset by several buy ratings and higher price targets. MarketBeat reports a consensus “Buy” rating and an average target of $19.80.
• The company has a $3.33 billion market capitalization and focuses on accumulating HYPE, the native token of the Hyperliquid blockchain. Institutional investors and hedge funds own 9.45% of its shares.

Hyperliquid Strategies Inc (NASDAQ:PURR - Get Free Report) gapped up before the market opened on Thursday. The stock had previously closed at $9.97, but opened at $11.28. Hyperliquid Strategies shares last traded at $10.9270, with a volume of 11,374,535 shares trading hands.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Weiss Ratings lowered Hyperliquid Strategies from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Friday, October 23rd. Wall Street Zen cut Hyperliquid Strategies from a "hold" rating to a "sell" rating in a research report on Sunday, October 11th. Cantor Fitzgerald upped their price target on Hyperliquid Strategies from $22.60 to $34.20 and gave the stock an "overweight" rating in a report on Thursday, September 10th. Chardan Capital raised their price objective on Hyperliquid Strategies from $9.75 to $17.00 and gave the company a "buy" rating in a report on Friday, August 28th. Finally, Compass Point initiated coverage on Hyperliquid Strategies in a research report on Monday, September 14th. They issued a "buy" rating and a $18.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $19.80.

Hyperliquid Strategies Stock Performance

The company has a market capitalization of $3.33 billion, a PE ratio of -1.84 and a beta of 1.89. The company has a 50 day simple moving average of $11.35 and a 200 day simple moving average of $7.95.

Institutional Trading of Hyperliquid Strategies

A number of hedge funds have recently bought and sold shares of PURR. Profund Advisors LLC increased its holdings in Hyperliquid Strategies by 4.2% in the 3rd quarter. Profund Advisors LLC now owns 91,907 shares of the company's stock valued at $1,128,000 after purchasing an additional 3,712 shares during the last quarter. ProShare Advisors LLC raised its holdings in shares of Hyperliquid Strategies by 46.5% in the 3rd quarter. ProShare Advisors LLC now owns 24,107 shares of the company's stock valued at $296,000 after buying an additional 7,647 shares during the period. VestGen Advisors LLC acquired a new position in Hyperliquid Strategies in the 3rd quarter valued at about $260,000. Oppenheimer & Co. Inc. increased its stake in Hyperliquid Strategies by 69.2% during the third quarter. Oppenheimer & Co. Inc. now owns 83,271 shares of the company's stock worth $1,022,000 after purchasing an additional 34,067 shares during the period. Finally, NTV Asset Management LLC acquired a new stake in shares of Hyperliquid Strategies during the third quarter worth about $123,000. Institutional investors and hedge funds own 9.45% of the company's stock.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.